Frontlight ResearchEarly access
Kidney cancer trials in Canada
15 of 19 trials · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)
- Where
- Ottawa, Québec
- Age
- 18 years and over
- People
- 758 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07489495 · EU 2024-516993-31-00 - Phase 1Taking peopleGCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours
- Where
- Calgary, Montreal, Ottawa, Toronto
- Age
- 15 years and over
- People
- 30
- Run by
- Canadian Cancer Trials Group
See details and how to joinNCT07297667 - Phase 3Taking peopleStudy of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
- Where
- Calgary, Edmonton, Hamilton, London, Montreal, Sherbrooke, Toronto, Vancouver
- Age
- 18 years and over
- People
- 720 worldwide
- Run by
- Arcus Biosciences, Inc.
See details and how to joinNCT07011719 · EU 2024-515023-11-00 - Phase 2SuspendedTesting the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
- Where
- Québec, Toronto
- Age
- 18 years and over
- People
- 240 worldwide
- Run by
- NRG Oncology
See details and how to joinNCT05327686 - Phase 1/2Not yet taking people in CanadaA Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
- Where
- Calgary, Edmonton, Montreal, Québec
- Age
- 18 years and over
- People
- 474 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07293351 · EU 2026-527163-15-00 - Phase 3Not yet taking people in CanadaThe Impact of Time-of-day-Dependent Administration of Nivolumab-Ipilimumab (ICI/ICI) Combination on Overall Survival in Adults With Advanced Kidney Cancer: A Pragmatic Multicenter, Randomized Controlled Trial.
- Where
- Vancouver
- Age
- 18 years and over
- People
- 142
- Run by
- Guliz Ozgun
See details and how to joinNCT07338981 - Phase 2Taking peopleA Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
- Where
- Calgary, Edmonton, Halifax, Hamilton, London, Montreal, Ottawa, Québec, Sherbrooke, St. John's, Toronto, Vancouver, Winnipeg
- Age
- Up to 30 years
- People
- 256 worldwide
- Run by
- Children's Oncology Group
See details and how to joinNCT04322318 - Phase 1/2Taking peopleA Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
- Where
- Edmonton, Hamilton, Montreal, Ottawa, Toronto, Vancouver
- Age
- 18 years and over
- People
- 1,109 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT04895709 - Phase 1Taking peopleA First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)
- Where
- Calgary
- Age
- 18 years and over
- People
- 281 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07195682 · EU 2025-522543-18-00 - Phase 1Taking peopleA Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors
- Where
- Montreal, Québec, Vancouver
- Age
- 18 years and over
- People
- 437 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06764771 - No phaseTaking peopleSABR for Renal Tumors
- Where
- Toronto
- Age
- 18 years and over
- People
- 90
- Run by
- University Health Network, Toronto
See details and how to joinNCT03747133 - Phase 1/2Taking peopleStudy of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
- Where
- Montreal, Toronto, Vancouver
- Age
- 12 months to 30 years
- People
- 90 worldwide
- Run by
- St. Jude Children's Research Hospital
See details and how to joinNCT04901702 - No phaseTaking peopleAssessment of Quality of Life and Outcomes in Patients With Primary Renal Cell Carcinoma Treated With SBRT
- Where
- Toronto
- Age
- 18 years and over
- People
- 70
- Run by
- Sunnybrook Health Sciences Centre
See details and how to joinNCT05023265 - Phase 2Taking peopleAblative Radioembolization of Renal Cell Carcinoma Trial
- Where
- London
- Age
- 18 years and over
- People
- 16
- Run by
- Derek W. Cool
See details and how to joinNCT06642220 - Phase 2Taking peopleAPL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- Where
- Edmonton, Montreal, Toronto, Winnipeg
- Age
- 18 years and over
- People
- 497 worldwide
- Run by
- Apollomics Inc.
See details and how to joinNCT03175224 · EU 2024-514542-37-00